Multiple Sclerosis Trial, Not Yet Recruiting NCT06387043 Sponsor: Halic University Condition: Multiple Sclerosis
Back to Multiple Sclerosis

Multiple Sclerosis Trial, Not Yet Recruiting

NCT06387043
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People aged between 18 and 50 years old
  • People who have been diagnosed with Multiple Sclerosis (MS) by a neurologist using a specific set of diagnostic guidelines called the McDonald 2017 criteria
  • People whose level of disability from MS falls within a specific range (between 2.5 and 4.5) on a standard MS disability scale called the Expanded Disability Status Scale (EDSS) — confirm with trial site what this means for a specific situation
  • People who have not had an MS attack or relapse in the past 3 months
  • People whose muscle stiffness (spasticity) in the arms or legs is mild enough that it would not interfere with the treatment, based on a standard stiffness scale
  • People who score 24 points or more on a standard mental function test called the Standardised Mini Mental Test (SMMT)

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have hearing or vision problems
  • People who are pregnant
  • People who have changed their MS medication in the last 3 months, or who are taking a medication that contains the active ingredient Fampridine
  • People who are currently taking part in, or have taken part in, a regular physiotherapy or rehabilitation program in the last 3 months
  • People who have other neurological, bone and joint, or balance-related conditions alongside their MS
  • People who have stiffness or tightness in an arm or leg joint severe enough to prevent them from doing exercises
  • People who have had an epileptic seizure, migraine attack, or vertigo attack in the last 6 months

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 7 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: GÜLSENA UTKU UMUT, HALİÇ UNİVERSİTY

Phone: +905370664646

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Halic University
Registry
ClinicalTrials.gov
Start date
1 December 2024
Est. completion
1 March 2025

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

Functional Near Infrared Ray Spectroscopy (fNIRS); Timed Up and Go Test; Functional Reach Test; Berg Balance Scale; Timed 25 Step Walking Test

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 7 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov